Egg Allergy Drug Pipeline Research 2024 Featuring Aimmune Therapeutics, DBV Technologies, and ASIT Biotech
12 avr. 2024 09h59 HE
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Egg allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Peanut Allergy Drug Landscape Analysis Report 2024: Comprehensive Insights of 12+ Companies and 15+ Pipeline Drugs
11 avr. 2024 09h11 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Peanut Allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Peanut Allergy - Pipeline Insight,...
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
05 févr. 2024 04h41 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19,...
Allergy Immunotherapy Market Size to Exceed USD 5.6 billion by 2031, with a Robust CAGR of 9.6%| States Transparency Market Research, Inc.
11 janv. 2024 11h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global allergy immunotherapy market is estimated to flourish at a CAGR of 9.6% from...
Allergy Immunotherapy Market Size to Surpass USD 3.20 Billion in 2030, exhibiting a CAGR of 9.5%
19 juin 2023 08h00 HE
|
Fortune Business Insights
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is anticipated to grow from USD 1.70 billion in 2023 to...
Sami Nallamshetty, MD, FACAAI Uses Immunotherapy as a Powerful Tool to Treat Asthma and Allergies
19 mai 2023 12h37 HE
|
Florida Medical Clinic
TAMPA. Fla., May 19, 2023 (GLOBE NEWSWIRE) -- “People might know that immunotherapy can fight allergies, but it can help asthma sufferers too,” says Dr. Nallamshetty, who specializes in pediatric...
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
27 mars 2023 04h00 HE
|
AKAMPION
- Study results indicate beneficial effects on airway hyperresponsiveness, remodeling and inflammation Geneva, Switzerland, March 27, 2023 – HpVac SA, a company developing novel preventive and...
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
23 nov. 2022 04h00 HE
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
Global Allergy Immunotherapy Market Size to grow USD 4.5 Billion by 2030 | CAGR of 9.5%; Spherical Insights & Consulting
24 oct. 2022 05h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, Oct. 24, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global Allergy Immunotherapy Market Size to grow from...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
18 oct. 2022 04h00 HE
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...